Page last updated: 2024-12-05

cupric acetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cupric acetate, also known as copper(II) acetate, is a chemical compound with the formula Cu(CH3COO)2. It is a blue-green crystalline solid that is soluble in water. Cupric acetate is commonly used as a catalyst in organic synthesis, particularly in the oxidation of alcohols and the preparation of esters. It is also used as a pigment and a wood preservative. Cupric acetate can be synthesized by reacting copper metal with acetic acid in the presence of oxygen. It can also be prepared by reacting copper oxide with acetic acid. Cupric acetate is known to be toxic and can cause irritation to the skin, eyes, and respiratory system. It is also a potential environmental hazard. Cupric acetate is studied because of its potential applications in a variety of fields, including catalysis, materials science, and medicine. Research is ongoing to explore its potential applications in these areas.'

Cross-References

ID SourceID
PubMed CID8895
SCHEMBL ID1080
MeSH IDM0064113

Synonyms (78)

Synonym
copper acetate (cu(c2h3o2)2)
copper diacetate
crystals of venus
cupric diacetate
cupric acetate
copper(2+) diacetate
nsc-75796
copper(2+) acetate
142-71-2
copper(ii) acetate
crystallized verdigris
acetic acid, copper(2+) salt
c4h6cuo4
hsdb 915
copper di(acetate)
ccris 5286
ai3-01379
nsc 75796
acetic acid, cupric salt
einecs 205-553-3
copper acetate (cu(oac)2)
octan mednaty [czech]
acetic acid, copper (2+) salt
acetate de cuivre [french]
venus copper
cu(ii) acetate
acetic acid copper(ii) salt
C2346
FT-0653868
cupric acetate, basic
acetic acid, copper(2+) salt, basic
einecs 257-974-7
52503-64-7
unii-39m11xph03
octan mednaty
acetate de cuivre
acetic acid, copper(2+) salt (2:1)
39m11xph03 ,
ec 205-553-3
AKOS015892699
copper (ii) acetate
cuprum aceticum
cuprum aceticum [hpus]
cupric acetate [inci]
copper(ii) acetate [hsdb]
copper acetate [mart.]
cupric acetate [mi]
copper acetate [who-dd]
SCHEMBL1080
copper (ii) diacetate
cu(oac)2
copper (ii)acetate
copper(ii)diacetate
diacetoxy copper (ii)
diacetoxycopper
copper-(ii)acetate
copper(ii)acetate
bisacetoxycopper
copper(ii) diacetate
copper(11) acetate
copper-(ii)-acetate
copper(1i) acetate
diacetoxy copper
copper-(ii) acetate
copper acetate salt
OPQARKPSCNTWTJ-UHFFFAOYSA-L
DTXSID2059720 ,
copper,bis(acetato-ko,ko')-
J-520114
D77909
copper(ii) acetate, trace metals grade
Q421854
acetic acid,copper salt
copper;diacetate
cuprum aceticum 4 special order
dtxcid8034613
cuprum aceticum 3
SY001104

Research Excerpts

Overview

ate is a potent inhibitor (Ki = 3.42 X 10(-6) M) of xanthine dehydrogenase activity.

ExcerptReferenceRelevance
"Cupric acetate is a potent inhibitor (Ki = 3.42 X 10(-6) M) of the xanthine dehydrogenase activity."( Effect of copper on blood serum xanthine dehydrogenase in rats given D-L-ethionine.
Affonso, OR; Mitidieri, E; Souza, AS, 1985
)
0.99
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (76)

TimeframeStudies, This Drug (%)All Drugs %
pre-199019 (25.00)18.7374
1990's12 (15.79)18.2507
2000's15 (19.74)29.6817
2010's29 (38.16)24.3611
2020's1 (1.32)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 68.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index68.87 (24.57)
Research Supply Index4.42 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index115.46 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (68.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (1.22%)4.05%
Observational0 (0.00%)0.25%
Other81 (98.78%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]